FDA Approved: NEUPOGEN — Supplemental Application (Amgen, Inc)

View source ↗

Summary

FDA approved a supplemental application for NEUPOGEN (filgrastim) submitted by Amgen, Inc. The action relates to the approval of changes in the product’s regula…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neutropenia

Drugs mentioned

• Neupogen (Filgrastim)

Snippet

SUPPL AP for NEUPOGEN (FILGRASTIM)